Repeat long QT syndrome genetic testing of phenotype-positive cases: Prevalence and etiology of detection misses

• Published in: Heart rhythm Vol. 9; no. 12; pp. 1977 - 1982
• Main Authors: Medlock, Morgan M., Tester, David J., Will, Melissa L., Bos, J. Martijn, Ackerman, Michael J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2012
• Subjects: Alleles; Cardiovascular; Chromatography, High Pressure Liquid; DNA - genetics; DNA Mutational Analysis; False Negative Reactions; Female; Genetic Predisposition to Disease; Genetic Testing - methods; Genetic testing, Mutation; Genetics; Genotype; Genotyping; Humans; Long QT syndrome; Long QT Syndrome - diagnosis; Long QT Syndrome - epidemiology; Long QT Syndrome - genetics; Male; Minnesota - epidemiology; Mutation; Prevalence; Reproducibility of Results; Young Adult; Minnesota; QTc; DHPLC; Genotyping; Genetic testing, Mutation; LQTS; Long QT syndrome; Genetics; SSCP; CLIA; PCR; corrected QT; single-stranded conformational polymorphism; Clinical Laboratory Improvement Amendments; polymerase chain reaction; denaturing high-performance liquid chromatography
• ISSN: 1547-5271; 1556-3871; 1556-3871
• DOI: 10.1016/j.hrthm.2012.08.010

Approximately 75% of long QT syndrome (LQTS) has been explained genetically through research-based and, more recently, commercial genetic testing. While novel LQTS-susceptibility genes or mutations in unexplored regions of known genes underlie the genetic mechanism for some of the 25% “genotype-negative” remnant, it is likely that some cases represent false-negative test results owing to mutation detection failures. To determine the prevalence and etiology of false negatives that occurred with research-based mutational analysis involving denaturing high-performance liquid chromatography (DHPLC) followed by DNA sequencing (DHPLC-SEQ) in our previously published cohort of unrelated patients referred for LQTS genetic testing. Forty-four LQTS cases (29 men, average age 23 ± 15 years, average corrected QT interval 516 ± 56 ms) deemed genotype negative following DHPLC-SEQ were selected for repeat genetic testing using direct DNA sequencing. LQTS-causing mutations were identified in 7 of 44 (16%) phenotype-positive/previously genotype-negative subjects, including 4 mutations in KCNQ1 (S225L, G568R, R591H, and R594Q), 2 in KCNH2 (H70R and G925R), and 1 in SCN5A (V411M). None of these variants were seen in more than 2600 reference alleles. Analysis of the misses revealed (1) normal DHPLC detection profile in 2, (2) allelic dropout in 2, (3) failure to correctly optimize DHPLC conditions in 1, and (4) failure to detect abnormal DHPLC signal in 2. Repeat genetic testing using direct DNA sequencing may be warranted for LQTS phenotype-positive individuals who were pronounced genotype negative during the decade of research-based mutational analysis that involved intermediate mutation detection methods such as DHPLC.